Intermittent Catheterization clinical trials

Explore recruiting intermittent catheterization clinical trials.

Recruiting intermittent catheterization studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Intermittent Catheterization trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy of intravesical oxybutynin in children with neurogenic bladder dysfunction: A randomized, prospective controlled multi-center trial.

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2/3, Open-label, Baseline-controlled, Multicenter, Long-term Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age with Neurogenic Detrusor Overactivity (NDO) on Clean Intermittent Catheterization (CIC)

Lithuania, Croatia, Latvia, Denmark, Romania, Belgium +3 more

Phase II and Phase III (Integrated) EU CTIS Study details

Intermittent Catheterization trials by city

Intermittent Catheterization clinical trials

Recruiting intermittent catheterization studies right now

Bacteriophage Therapy in Spinal Cord Injury Patients With Bacteriuria

Conversion of Evidence and Applied Research on Intermittent Catheterization After Radical Hysterectomy

Effect of Mobile Application- and AI Supported Video-Based Patient Education on Patient Outcomes in Teaching Clean Intermittent Catheterization

Comparison of Urinary Flow Study

Dose Escalation Study of EG110A, Administered by Intradetrusor Injections to Adults With Neurogenic Detrusor Overactivity-related Incontinence Following Spinal Cord Injury Who Regularly Perform Clean Intermittent Catheterization

Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder Dysfunction

Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC

Also recruiting in Europe

Efficacy of intravesical oxybutynin in children with neurogenic bladder dysfunction: A randomized, prospective controlled multi-center trial.

A Phase 2/3, Open-label, Baseline-controlled, Multicenter, Long-term Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age with Neurogenic Detrusor Overactivity (NDO) on Clean Intermittent Catheterization (CIC)

Intermittent Catheterization trials by city

Other conditions